1. University of Patras, Medical Faculty, Laboratory of General Biology, Patras, Greece;
2. School of Health Sciences, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Greece;
3. United Arab Emirates University, College of Medicine and Health Sciences, Department of Pathology, Al-Ain, United Arab Emirates;
4. School of Science and Technology, Biology Laboratory, Hellenic Open University, Patras, Greece;
5. Thalassemia and Hemoglobinopathies Unit, Hematology Division, Department of Internal Medicine, University of Patras Medical School, University Hospital, Patras, Greece;
6. Medical School, Hematology Division, Department of Internal Medicine, University of Patras, University of Patras, Greece;
7. Adults Thalassemia Unit, ‘Hippokration’ General Hospital of Thessaloniki, Greece;
8. Thalassemia and Sickle Cell Unit, University General Hospital of Thessaloniki, Greece;
9. United Arab Emirates University, Zayed Center of Health Sciences, Al-Ain, United Arab Emirates